Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China · Delayed Price · Currency is CNY 3.900
-0.050 (-1.27%)
Sep 10, 2026, 1:15 PM CST
SHE:300194 Revenue
Fuan Pharmaceutical (Group) had revenue of 431.80M CNY in the quarter ending June 30, 2026, a decrease of -4.64%. This brings the company's revenue in the last twelve months to 1.66B, down -11.81% year-over-year. In the year 2025, Fuan Pharmaceutical (Group) had annual revenue of 1.74B, down -27.31%.
Revenue (ttm)
1.66B
Revenue Growth
-11.81%
P/S Ratio
2.84
Revenue / Employee
554.58K
Employees
2,988
Market Cap
4.70B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.74B | -653.18M | -27.31% |
| Dec 31, 2024 | 2.39B | -256.28M | -9.68% |
| Dec 31, 2023 | 2.65B | 226.01M | 9.33% |
| Jan 1, 2023 | 2.42B | -31.40M | -1.28% |
| Jan 1, 2022 | 2.45B | 84.80M | 3.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Yabao Pharmaceutical Group | 2.25B |
| Hunan Fangsheng Pharmaceutical | 1.87B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.73B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.56B |
| Beijing Beilu Pharmaceutical | 1.29B |
| Hunan Hansen Pharmaceutical | 1.01B |
| Qianjiang Yongan Pharmaceutical | 979.49M |
| LanZhou Foci Pharmaceutical | 926.49M |